Lymphoid Leukemia
📧 Sign up to get email alerts when something new happens for Lymphoid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients [Phase 2]
Phase 2 trial update on intravenous vitamin C use in allogeneic stem cell transplant recipients, with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL [Phase 1, Phase 2]
Dose-escalation early-stage trial assessing safety of PBCAR20A in relapsed/refractory Non-Hodgkin's Lymphoma and relapsed/refractory Chronic…
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis [Phase 2]
Phase 2 trial of adoptive immunotherapy in relapsed hematological malignancies with early GVHD prophylaxis has completed enrollment and post…
-
CLINICAL_TRIALS trial_result · 2022-04-11Clinical Trial Update: Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial investigating bendamustine and rituximab in combination with copanlisib for chronic lymphocytic leukemia or small lymphocytic …
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial of ABT-263 in relapsed or refractory lymphoid malignancies has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: The Effect of 25-OH-Vitamin-D3 Substitution in Patients With Malignant and Immune-hematologic Diseases [Phase 3]
Phase 3 trial evaluating 25-OH-Vitamin-D3 substitution in patients with chronic lymphoid leukemia; study terminated.
-
CLINICAL_TRIALS trial_result · 2020-01-13Clinical Trial Update: Irradiation-based Myeloablative Conditioning Followed by Treg/Tcon Immunotherapy in HSCT [Phase 2]
Phase 2 clinical trial evaluating irradiation-based myeloablative conditioning followed by regulatory T cell and conventional T cell immunot…
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133 [Phase 1, Phase 2]
Phase 1/2 trial evaluating CART133 for relapsed/chemo-refractory advanced malignancies completed, across multiple cancers.
-
CLINICAL_TRIALS trial_result · 2019-01-08Clinical Trial Update: Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant [Phase 2]
Phase II multicenter trial evaluating CD26 inhibition with sitagliptin for engraftment after umbilical cord blood transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients [Phase 2]
Phase 2 trial evaluating Oshadi D and Oshadi R combined with salvage chemotherapy in relapsed acute myeloid leukemia and lymphoid leukemia i…
-
CLINICAL_TRIALS trial_result · 2015-12-07Clinical Trial Update: Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating Anti-Tac labeled with Yttrium-90 (90Y-HAT) for Hodgkin lymphoma, Non-Hodgkin lymphoma, and lymphoid leuk…